Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China flag China · Delayed Price · Currency is CNY
26.92
+0.38 (1.43%)
At close: Apr 30, 2026

SHE:301089 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
3,3583,5433,5676,8359,07210,130
Market Cap Growth
-10.00%-0.67%-47.81%-24.66%-10.45%-
Enterprise Value
3,1313,2923,2106,4838,68210,148
Last Close Price
26.5428.0028.1953.6671.1579.45
PE Ratio
---28.1231.66154.17
PS Ratio
8.989.378.468.1811.5620.16
PB Ratio
2.282.392.304.266.599.23
P/TBV Ratio
2.412.522.434.507.0210.00
P/FCF Ratio
--190.19-75.28-
P/OCF Ratio
8109.73-34.75253.5733.74174.08
EV/Sales Ratio
8.378.707.617.7611.0620.20
EV/EBITDA Ratio
--514.3418.7224.9388.37
EV/EBIT Ratio
---21.6328.21120.93
EV/FCF Ratio
-77.73-171.12-72.04-
Debt / Equity Ratio
0.000.000.00-0.030.06
Debt / EBITDA Ratio
--0.64-0.110.60
Debt / FCF Ratio
--0.23-0.33-
Net Debt / Equity Ratio
-0.15-0.16-0.20-0.21-0.37-0.40
Net Debt / EBITDA Ratio
12.2112.49-50.62-0.98-1.46-3.79
Net Debt / FCF Ratio
5.663.43-16.842.14-4.217.98
Asset Turnover
0.220.220.230.450.490.43
Inventory Turnover
1.531.651.621.641.621.92
Quick Ratio
2.482.712.983.021.812.39
Current Ratio
4.114.014.104.232.393.13
Return on Equity (ROE)
-5.07%-4.59%-1.26%16.32%23.17%8.28%
Return on Assets (ROA)
-3.25%-3.09%-1.43%10.17%11.89%4.48%
Return on Invested Capital (ROIC)
-7.11%-6.83%-3.29%21.58%35.42%12.08%
Return on Capital Employed (ROCE)
-5.90%-5.60%-2.60%18.20%21.70%7.40%
Earnings Yield
-2.28%-1.97%-0.56%3.56%3.16%0.65%
FCF Yield
-1.20%-1.99%0.53%-2.32%1.33%-0.54%
Dividend Yield
---0.47%0.56%0.13%
Payout Ratio
---20.85%5.23%12.05%
Buyback Yield / Dilution
-1.30%-1.91%1.32%0.22%-26.78%-5.03%
Total Shareholder Return
-1.30%-1.91%1.32%0.69%-26.22%-4.91%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.